Search Results

There are 9416 results for: content related to: The first recombinant FVIII produced in human cells – an update on its clinical development programme

  1. You have free access to this content
    Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 2–16, P. M. Mannucci, Q. Shi, S. Bonanad and R. Klamroth

    Article first published online : 26 JUN 2014, DOI: 10.1111/hae.12465

    Corrected by:

    Erratum: Erratum

    Vol. 20, Issue 5, e376, Article first published online: 28 AUG 2014

  2. You have free access to this content
    New predictive approaches for ITI treatment

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 27–43, G. D. Minno, E. Santagostino, K. Pratt and C. Königs

    Article first published online : 26 JUN 2014, DOI: 10.1111/hae.12467

  3. In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile

    Haemophilia

    Volume 19, Issue 3, May 2013, Pages: 392–398, S. Pahl, A. Pavlova, J. Driesen, J. Müller, B. Pötzsch and J. Oldenburg

    Article first published online : 18 DEC 2012, DOI: 10.1111/hae.12076

  4. You have full text access to this OnlineOpen article
    Native plasma-derived FVIII/VWF complex has lower sensitivity to FVIII inhibitors than the combination of isolated FVIII and VWF proteins. Impact on Bethesda assay titration of FVIII inhibitors

    Haemophilia

    Volume 20, Issue 6, November 2014, Pages: 905–911, M. I. Bravo, B. Da Rocha-Souto, S. Grancha and J. I. Jorquera

    Article first published online : 25 AUG 2014, DOI: 10.1111/hae.12494

  5. Monitoring rFVIII prophylaxis dosing using global haemostasis assays

    Haemophilia

    Volume 19, Issue 3, May 2013, Pages: 409–414, M. A. AL Hawaj, E. J. Martin, J. Venitz, J. C. Barrett, J. G. Kuhn, M. E. Nolte and D. F. Brophy

    Article first published online : 19 MAR 2013, DOI: 10.1111/hae.12110

  6. Prolonged effect of a new O-glycoPEGylated FVIII (N8-GP) in a murine saphenous vein bleeding model

    Haemophilia

    Volume 19, Issue 6, November 2013, Pages: 913–919, A. E. Pastoft, M. Ezban, M. Tranholm, J. Lykkesfeldt and B. Lauritzen

    Article first published online : 4 JUN 2013, DOI: 10.1111/hae.12198

  7. You have full text access to this OnlineOpen article
    Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories

    Haemophilia

    Volume 20, Issue 2, March 2014, Pages: 294–300, J. M. Sommer, N. Moore, B. McGuffie-Valentine, S. Bardan, Y. Buyue, G. D. Kamphaus, B. A. Konkle and G. F. Pierce

    Article first published online : 22 NOV 2013, DOI: 10.1111/hae.12296

  8. You have full text access to this OnlineOpen article
    Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS

    Haemophilia

    Volume 20, Issue 1, January 2014, Pages: e15–e22, S. Lalezari, U. Martinowitz, J. Windyga, M. M. Enriquez, H. Delesen, L. Schwartz and I. Scharrer

    Article first published online : 20 NOV 2013, DOI: 10.1111/hae.12294

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 20, Issue 2, e193, Article first published online: 18 FEB 2014

  9. Product-dependent anti-factor VIII antibodies

    Haemophilia

    Volume 19, Issue 4, July 2013, Pages: 619–625, S. Butenas, J. Krudysz-Amblo, G. E. Rivard and K. G Mann

    Article first published online : 4 APR 2013, DOI: 10.1111/hae.12127

  10. A quantitative and humane tail bleeding assay for efficacy evaluation of antihaemophilic factors in haemophilia A mice

    Haemophilia

    Volume 20, Issue 6, November 2014, Pages: e392–e398, E. S. Molina, A. Fujita, M. C. Sogayar and M. A. Demasi

    Article first published online : 26 JUN 2014, DOI: 10.1111/hae.12484

  11. Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A

    Haemophilia

    Volume 20, Issue 4, July 2014, Pages: 593–600, J-M. Gu, P. Ramsey, V. Evans, L. Tang, H. Apeler, L. Leong, J. E. Murphy, V. Laux and T. Myles

    Article first published online : 29 JAN 2014, DOI: 10.1111/hae.12374

  12. Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study

    Haemophilia

    Volume 20, Issue 3, May 2014, Pages: 354–361, S. Lalezari, A. COPPOLA, J. Lin, M. M. Enriquez, D. Tseneklidou-Stoeter, J. Powell, J. Ingerslev and On Behalf of The LIPLONG Investigators

    Article first published online : 20 NOV 2013, DOI: 10.1111/hae.12306

  13. Pharmacokinetics of plasma-derived vs. recombinant FVIII concentrates: a comparative study

    Haemophilia

    M. Morfini, E. Marchesini, E. Paladino, C. Santoro, E. Zanon and A. Iorio

    Article first published online : 2 OCT 2014, DOI: 10.1111/hae.12550

  14. Recombinant factor VIIa enhances platelet deposition from flowing haemophilic blood but requires the contact pathway to promote fibrin deposition

    Haemophilia

    R. Li, K. A. Panckeri, P. F. Fogarty and S. L. Diamond

    Article first published online : 14 OCT 2014, DOI: 10.1111/hae.12558

  15. You have free access to this content
    ITI choice for the optimal management of inhibitor patients – from a clinical and pharmacoeconomic perspective

    Haemophilia

    Volume 20, Issue s6, September 2014, Pages: 17–26, J. Oldenburg, S. K. Austin and C. M. Kessler

    Article first published online : 26 JUN 2014, DOI: 10.1111/hae.12466

  16. Computer-predicted peptides that mimic discontinuous epitopes on the A2 domain of factor VIII

    Haemophilia

    A. Lebreton, N. Simon, V. Moreau, V. Demolombe, C. Cayzac, C. Nguyen, J.-F. Schved, C. Granier and G. Lavigne-Lissalde

    Article first published online : 24 NOV 2014, DOI: 10.1111/hae.12575

  17. You have full text access to this OnlineOpen article
    Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate

    Haemophilia

    Volume 20, Issue 1, January 2014, Pages: 83–91, J. Oldenburg, V. Jiménez-Yuste, R. Peiró-Jordán, L. M. Aledort and E. Santagostino

    Article first published online : 19 NOV 2013, DOI: 10.1111/hae.12263

  18. Infection risk and stability of a continuous 8-h 250 mL rFVIII infusion

    Haemophilia

    Volume 20, Issue 2, March 2014, Pages: 212–218, A. Lambing, P. Kuriakose and L. M. Mueller

    Article first published online : 20 NOV 2013, DOI: 10.1111/hae.12292

  19. You have free access to this content
    Third Åland islands conference on von Willebrand disease, 26–28 September 2012: meeting report

    Haemophilia

    Volume 19, Issue s3, March 2013, Pages: 1–18, E. Berntorp, B. Fuchs, M. Makris, R. Montgomery, V. Flood, J. S. O'Donnell, A. B. Federici, D. Lillicrap, P. James, U. Budde, M. Morfini, P. Petrini, S. Austin, C. Kannicht, V. Jiménez-Yuste and C. Lee

    Article first published online : 6 FEB 2013, DOI: 10.1111/hae.12078

  20. Practical and cost-effective measurement of B-domain deleted and full-length recombinant FVIII in the routine haemostasis laboratory

    Haemophilia

    Volume 19, Issue 3, May 2013, Pages: e133–e138, M. Cauchie, J. Toelen, K. Peerlinck and M. Jacquemin

    Article first published online : 4 FEB 2013, DOI: 10.1111/hae.12093